Cbk Med Clinic
- Address
- Aleja Marsz. Jozefa Pilsudskiego 35/w2 Lok 105, 09-407 Płock, Poland
CBK Med Clinic - Respiratory and Cardiovascular Research Center
CBK Med Clinic Sp. z o.o. is a specialized clinical research facility with extensive expertise in respiratory medicine and cardiovascular disease prevention. The center demonstrates particular strength in conducting Phase III trials for chronic obstructive pulmonary disease (COPD) and asthma, with a focus on evaluating innovative therapeutic approaches including novel biologics, combination therapies, and advanced drug delivery systems.
- Chronic Obstructive Pulmonary Disease (COPD) trials evaluating triple therapy combinations, bronchodilators, and biologic agents for exacerbation prevention
- Asthma research focusing on safety and tolerability of inhaled medications and propellant formulations
- Cardiovascular prevention studies investigating heart failure risk reduction strategies
- Dermatological research in atopic dermatitis and immunological conditions
The clinic has demonstrated capability in managing complex respiratory trials involving metered-dose inhalers, combination pharmacotherapies, and long-term safety assessments. Their research portfolio includes evaluation of cardiopulmonary outcomes and exacerbation reduction strategies in COPD patients, as well as investigations into preventive cardiovascular interventions. This diverse therapeutic expertise positions CBK Med Clinic as a comprehensive research center capable of conducting multi-phase clinical trials across respiratory, cardiovascular, and dermatological therapeutic areas.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 4 by active trials.
- 1AstraZeneca AB5active
lock +3 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1AstraZeneca AB7trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Cbk Med Clinic
lock Showing 1 of 11 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Multicentre, Parallel-group, Phase IIb, Randomised, Double blind, Placebo-controlled, 4-Arm, 24-Week Study to Evaluate the Efficacy and Safety of AZD6793 Tablets in Adult Participants with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (PRESTO). | AstraZeneca AB | Phase II | Recruiting | Sep 2025 | — |
IMP list
lock Showing 1 of 12 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Salbutamol | 2 | Unknown | 2024-02-12 | 2024-07-04 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.